INTRODUCTION:Physical exercise is associated with enhanced production of reactive oxygen species, which if uncontrolled can result in tissue injury. Phosphodiesterase type 5 inhibitors (PDE5i) exhibit protective effect against oxidative stress, both in animals and healthy/unhealthy humans. However, the effect of a chronic administration of PDE5i, particularly combined with physical exercise, has never been investigated. PURPOSE: The present study was designed to evaluate the effect of the long-acting PDE5i tadalafil on oxidative status and muscle damage after exhaustive exercise in healthy males included in a double-blind crossover trial. HYPOTHESIS: Tadalafil, having a putative antioxidant activity, may reduce oxidative damage after strenuous exercise. METHODS: Each volunteer randomly received two tablets of placebo or tadalafil (20 mg/day) with 36 h of interval before performing exhaustive exercise. After 2 weeks of washout, the volunteers were crossed over. Blood samples were collected immediately before exercise, immediately after, and during recovery (15, 30, 60 min). Plasma total antioxidant status, glutathione homeostasis (GSH/GSSG), malondialdehyde (MDA), protein carbonyls, creatine kinase (CK), lactate dehydrogenase (LDH) and the inflammatory cytokine interleukin 6 were assessed. RESULTS:Tadalafil administration per se affected redox homeostasis (GSH/GSSG -36%; p < 0.05), cellular (CK +75% and LDH +36%; p < 0.05) and oxidative damage (MDA +41% and protein carbonyls +50%; p < 0.05) markers. The exhaustive exercise increased all the above-reported biochemical parameters, with subjects from the tadalafil group showing significantly higher values with respect to the placebo group. CONCLUSIONS: A prolonged exposure to tadalafil decreases antioxidant capacity at resting condition, therefore making subjects more susceptible to the oxidative stress induced by an exhaustive bout of exercise.
RCT Entities:
INTRODUCTION: Physical exercise is associated with enhanced production of reactive oxygen species, which if uncontrolled can result in tissue injury. Phosphodiesterase type 5 inhibitors (PDE5i) exhibit protective effect against oxidative stress, both in animals and healthy/unhealthy humans. However, the effect of a chronic administration of PDE5i, particularly combined with physical exercise, has never been investigated. PURPOSE: The present study was designed to evaluate the effect of the long-acting PDE5i tadalafil on oxidative status and muscle damage after exhaustive exercise in healthy males included in a double-blind crossover trial. HYPOTHESIS: Tadalafil, having a putative antioxidant activity, may reduce oxidative damage after strenuous exercise. METHODS: Each volunteer randomly received two tablets of placebo or tadalafil (20 mg/day) with 36 h of interval before performing exhaustive exercise. After 2 weeks of washout, the volunteers were crossed over. Blood samples were collected immediately before exercise, immediately after, and during recovery (15, 30, 60 min). Plasma total antioxidant status, glutathione homeostasis (GSH/GSSG), malondialdehyde (MDA), protein carbonyls, creatine kinase (CK), lactate dehydrogenase (LDH) and the inflammatory cytokine interleukin 6 were assessed. RESULTS:Tadalafil administration per se affected redox homeostasis (GSH/GSSG -36%; p < 0.05), cellular (CK +75% and LDH +36%; p < 0.05) and oxidative damage (MDA +41% and protein carbonyls +50%; p < 0.05) markers. The exhaustive exercise increased all the above-reported biochemical parameters, with subjects from the tadalafil group showing significantly higher values with respect to the placebo group. CONCLUSIONS: A prolonged exposure to tadalafil decreases antioxidant capacity at resting condition, therefore making subjects more susceptible to the oxidative stress induced by an exhaustive bout of exercise.
Authors: Gregory D Lewis; Justine Lachmann; Janice Camuso; John J Lepore; Jordan Shin; Maryann E Martinovic; David M Systrom; Kenneth D Bloch; Marc J Semigran Journal: Circulation Date: 2006-12-18 Impact factor: 29.690
Authors: Zhongbing Lu; Xin Xu; Xinli Hu; Sangjin Lee; Jay H Traverse; Guangshuo Zhu; John Fassett; Yi Tao; Ping Zhang; Cris dos Remedios; Marc Pritzker; Jennifer L Hall; Daniel J Garry; Yingjie Chen Journal: Circulation Date: 2010-03-22 Impact factor: 29.690
Authors: L Speranza; S Franceschelli; M Pesce; I Vinciguerra; M A De Lutiis; A Grilli; M Felaco; A Patruno Journal: Int J Immunopathol Pharmacol Date: 2008 Oct-Dec Impact factor: 3.219
Authors: H Perk; A Armagan; M Naziroğlu; S Soyupek; M B Hoscan; R Sütcü; A Ozorak; N Delibas Journal: J Clin Pharm Ther Date: 2008-12 Impact factor: 2.512
Authors: L Di Luigi; C Baldari; F Pigozzi; G P Emerenziani; M C Gallotta; F Iellamo; E Ciminelli; P Sgrò; F Romanelli; A Lenzi; L Guidetti Journal: Int J Sports Med Date: 2007-07-05 Impact factor: 3.118
Authors: Guglielmo Duranti; Roberta Ceci; Paolo Sgrò; Stefania Sabatini; Luigi Di Luigi Journal: Cell Stress Chaperones Date: 2017-03-11 Impact factor: 3.667
Authors: P Sgrò; C Minganti; M Lista; C Antinozzi; M Cappa; Y Pitsiladis; F Pigozzi; L Di Luigi Journal: J Endocrinol Invest Date: 2020-09-18 Impact factor: 4.256
Authors: Cristina Antinozzi; Guglielmo Duranti; Roberta Ceci; Marco Lista; Stefania Sabatini; Daniela Caporossi; Luigi Di Luigi; Paolo Sgrò; Ivan Dimauro Journal: Int J Mol Sci Date: 2022-06-12 Impact factor: 6.208
Authors: Andrea Sansone; Massimiliano Sansone; Diana Vaamonde; Paolo Sgrò; Ciro Salzano; Francesco Romanelli; Andrea Lenzi; Luigi Di Luigi Journal: Reprod Biol Endocrinol Date: 2018-11-12 Impact factor: 5.211
Authors: Paolo Sgrò; Roberta Ceci; Marco Lista; Federica Patrizio; Stefania Sabatini; Francesco Felici; Massimo Sacchetti; Ilenia Bazzucchi; Guglielmo Duranti; Luigi Di Luigi Journal: Front Endocrinol (Lausanne) Date: 2021-11-03 Impact factor: 5.555